DE2855001A1 - Pharmazeutisches praeparat und seine herstellung - Google Patents
Pharmazeutisches praeparat und seine herstellungInfo
- Publication number
- DE2855001A1 DE2855001A1 DE19782855001 DE2855001A DE2855001A1 DE 2855001 A1 DE2855001 A1 DE 2855001A1 DE 19782855001 DE19782855001 DE 19782855001 DE 2855001 A DE2855001 A DE 2855001A DE 2855001 A1 DE2855001 A1 DE 2855001A1
- Authority
- DE
- Germany
- Prior art keywords
- preparation according
- tablet
- bis
- bicarbonate
- chromone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title claims description 5
- 238000004519 manufacturing process Methods 0.000 title claims description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 29
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 10
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 7
- -1 alkaline earth metal carbonate Chemical class 0.000 claims description 6
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 claims description 5
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 5
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- IMZMKUWMOSJXDT-UHFFFAOYSA-N cromoglycic acid Chemical compound O1C(C(O)=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C(O)=O)O2 IMZMKUWMOSJXDT-UHFFFAOYSA-N 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 3
- 230000002496 gastric effect Effects 0.000 claims description 3
- 235000015497 potassium bicarbonate Nutrition 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- 239000003513 alkali Substances 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 2
- 235000011181 potassium carbonates Nutrition 0.000 claims description 2
- 235000015424 sodium Nutrition 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 238000009472 formulation Methods 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000002253 acid Substances 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 150000004777 chromones Chemical class 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000008105 immune reaction Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 229940037627 magnesium lauryl sulfate Drugs 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- HBNDBUATLJAUQM-UHFFFAOYSA-L magnesium;dodecyl sulfate Chemical compound [Mg+2].CCCCCCCCCCCCOS([O-])(=O)=O.CCCCCCCCCCCCOS([O-])(=O)=O HBNDBUATLJAUQM-UHFFFAOYSA-L 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- RNFJDJUURJAICM-UHFFFAOYSA-N 2,2,4,4,6,6-hexaphenoxy-1,3,5-triaza-2$l^{5},4$l^{5},6$l^{5}-triphosphacyclohexa-1,3,5-triene Chemical compound N=1P(OC=2C=CC=CC=2)(OC=2C=CC=CC=2)=NP(OC=2C=CC=CC=2)(OC=2C=CC=CC=2)=NP=1(OC=1C=CC=CC=1)OC1=CC=CC=C1 RNFJDJUURJAICM-UHFFFAOYSA-N 0.000 description 1
- 208000004300 Atrophic Gastritis Diseases 0.000 description 1
- GGDZPAVQCDJVQX-UHFFFAOYSA-N C(CC)O.[Na].[Na] Chemical compound C(CC)O.[Na].[Na] GGDZPAVQCDJVQX-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 208000011231 Crohn disease Diseases 0.000 description 1
- 244000089409 Erythrina poeppigiana Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000004262 Food Hypersensitivity Diseases 0.000 description 1
- 206010016946 Food allergy Diseases 0.000 description 1
- 208000036495 Gastritis atrophic Diseases 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 235000009776 Rathbunia alamosensis Nutrition 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000016644 chronic atrophic gastritis Diseases 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229960000265 cromoglicic acid Drugs 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical class [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 description 1
- VLARUOGDXDTHEH-UHFFFAOYSA-L disodium cromoglycate Chemical compound [Na+].[Na+].O1C(C([O-])=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C([O-])=O)O2 VLARUOGDXDTHEH-UHFFFAOYSA-L 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 239000003063 flame retardant Substances 0.000 description 1
- 235000020932 food allergy Nutrition 0.000 description 1
- 201000005298 gastrointestinal allergy Diseases 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 208000002551 irritable bowel syndrome Diseases 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000001175 peptic effect Effects 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229940001593 sodium carbonate Drugs 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB53825/77A GB1595220A (en) | 1977-12-23 | 1977-12-23 | Tablets containing 1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2855001A1 true DE2855001A1 (de) | 1979-07-05 |
Family
ID=10469110
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19782855001 Withdrawn DE2855001A1 (de) | 1977-12-23 | 1978-12-20 | Pharmazeutisches praeparat und seine herstellung |
Country Status (18)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07116017B2 (ja) * | 1986-05-17 | 1995-12-13 | アース製薬株式会社 | 入浴剤 |
| GB9824604D0 (en) | 1998-11-11 | 1999-01-06 | Hewlett Healthcare Limited | Treatment of allergic conditions |
| JP2004514732A (ja) * | 2000-12-06 | 2004-05-20 | ファルマシア・コーポレーション | 迅速に分散する医薬組成物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2132521A1 (en) * | 1971-04-06 | 1972-11-24 | Sofrader Sa | Effervescent tablets prdn - by controlled drying in effervescent granule formation |
| GB1423985A (en) * | 1972-02-15 | 1976-02-04 | Fisons Ltd | Pharmaceutical compositions containing bischromonyloxy compounds |
| GB1517153A (en) * | 1974-11-30 | 1978-07-12 | Fisons Ltd | Naphthopyran-and benzodipyran-2-carboxylic acids and derivatives thereof |
| GB1570993A (en) * | 1976-05-21 | 1980-07-09 | Fisons Ltd | Pharmaceutical tablet formulation |
| GB1557082A (en) * | 1977-01-25 | 1979-12-05 | Fisons Ltd | Pharmaceutical mixture containing an antiinflammatory |
-
1977
- 1977-12-23 GB GB53825/77A patent/GB1595220A/en not_active Expired
-
1978
- 1978-12-18 AU AU42654/78A patent/AU523616B2/en not_active Expired
- 1978-12-18 IL IL56239A patent/IL56239A/xx unknown
- 1978-12-18 DK DK568278A patent/DK568278A/da not_active Application Discontinuation
- 1978-12-19 CH CH1290478A patent/CH641349A5/fr not_active IP Right Cessation
- 1978-12-19 FI FI783897A patent/FI783897A7/fi unknown
- 1978-12-19 SE SE7813062A patent/SE7813062L/xx unknown
- 1978-12-20 NL NL7812344A patent/NL7812344A/xx not_active Application Discontinuation
- 1978-12-20 ZA ZA00787155A patent/ZA787155B/xx unknown
- 1978-12-20 NZ NZ189255A patent/NZ189255A/en unknown
- 1978-12-20 BE BE192444A patent/BE872918A/xx not_active IP Right Cessation
- 1978-12-20 DE DE19782855001 patent/DE2855001A1/de not_active Withdrawn
- 1978-12-20 IT IT7831068A patent/IT7831068A0/it unknown
- 1978-12-21 JP JP15697478A patent/JPS5489016A/ja active Pending
- 1978-12-21 IE IE2540/78A patent/IE47539B1/en unknown
- 1978-12-21 CA CA318,406A patent/CA1108992A/en not_active Expired
- 1978-12-22 FR FR7836221A patent/FR2412310A1/fr active Granted
- 1978-12-22 LU LU80721A patent/LU80721A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SE7813062L (sv) | 1979-06-24 |
| FI783897A7 (fi) | 1979-06-24 |
| IT7831068A0 (it) | 1978-12-20 |
| BE872918A (fr) | 1979-06-20 |
| IE47539B1 (en) | 1984-04-18 |
| AU4265478A (en) | 1979-06-28 |
| GB1595220A (en) | 1981-08-12 |
| ZA787155B (en) | 1979-12-27 |
| NL7812344A (nl) | 1979-06-26 |
| CH641349A5 (en) | 1984-02-29 |
| DK568278A (da) | 1979-06-24 |
| NZ189255A (en) | 1984-05-31 |
| JPS5489016A (en) | 1979-07-14 |
| FR2412310B1 (enrdf_load_stackoverflow) | 1982-12-31 |
| IE782540L (en) | 1979-06-23 |
| IL56239A0 (en) | 1979-03-12 |
| AU523616B2 (en) | 1982-08-05 |
| IL56239A (en) | 1983-02-23 |
| FR2412310A1 (fr) | 1979-07-20 |
| LU80721A1 (fr) | 1979-09-07 |
| CA1108992A (en) | 1981-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69821553T2 (de) | Granulatzubereitung enthaltend Simethicon und granuliertes wasserfreies Calciumphosphat | |
| DE69110969T2 (de) | Verwendung von Triclosan zur Behandlung von Krankheiten des Gastrointestinaltraktes. | |
| EP0108898B1 (de) | Neue orale Mopidamolformen | |
| DE69712332T2 (de) | Beta-lactam-antibiotikum enthaltende tabletten und verfahren zu deren herstellung | |
| DE69925016T2 (de) | Verbesserte tablette mit schneller auflösbarkeit | |
| DE2845326C2 (de) | Verwendung einer spezifischen mikrodispersen, amorphen, porösen Kieselsäure zur Herstellung von Digoxin enthaltenden Tabletten mit stark beschleunigter Wirkstoff-Freisetzung | |
| DE2611041C2 (enrdf_load_stackoverflow) | ||
| AT398166B (de) | Verfahren zur herstellung einer pharmazeutischen kapsel zur oralen verabreichung von nitrofurantoin (-salzen, -hydraten, -komplexen) | |
| DE2518270A1 (de) | Verfahren zur herstellung von leicht zerfallenden tabletten | |
| DE202004021169U1 (de) | Pharmazeutische Formulierung, die Lanthanverbindungen enthält | |
| DE3132518A1 (de) | "alkalische, analgetische kapsel" | |
| DE2813480A1 (de) | Arzneimittel-depotpraeparat vom mehrfacheinheitsdosen-typ | |
| DE1492107A1 (de) | Verfahren zur Herstellung einer Tablette | |
| DE69814850T2 (de) | Paracetamol enthaltende schlickbare tablette | |
| DE69518237T2 (de) | Feste pharmazeutische zubereitung mit (s)-2-(4-isobutylphenyl)propionsäure als wirkstoff und mikrokristalliner cellulose und kolloidalem silica als hilfstoff | |
| EP0275468B1 (de) | Clodronat-haltige Arzneimittel und Verfahren zur Herstellung derselben | |
| EP1140013B1 (de) | Schäumende antacida-suspensionstabletten | |
| EP0625355B1 (de) | Tablette mit verbesserter Bioverfügbarkeit enthaltend Dichlormethylendiphosphonsäure als Wirkstoff | |
| DE69433012T2 (de) | Verfahren zur herstellung von oralen dosierungsformulierungen enthaltend diclofenac | |
| EP0591363A1 (de) | Torasemid-haltige pharmazeutische zusammensetzungen | |
| DE2519528C2 (enrdf_load_stackoverflow) | ||
| DE60005469T2 (de) | Arzneizusammensetzung enthaltend Ascorbinsäure und Pektin | |
| DE2855001A1 (de) | Pharmazeutisches praeparat und seine herstellung | |
| DE3530780C2 (de) | Neue pharmazeutische Verwendung von 5-(3-n-Butyloxalylaminophenyl)-tetrazol | |
| DE2062715B2 (de) | Verfahren zur herstellung von oral applizierbaren arzneimittelzubereitungen mit protrahierter wirkstoffabgabe und arzneimittelzubereitung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8127 | New person/name/address of the applicant |
Owner name: FISONS PLC, IPSWICH, SUFFOLK, GB |
|
| 8128 | New person/name/address of the agent |
Representative=s name: WUESTHOFF, F., DR.-ING. FRHR. VON PECHMANN, E., DI |
|
| 8141 | Disposal/no request for examination |